4530 Share Price Performance
JP¥6,300.00
1757.00 (38.67%)
Price JP¥6,300.00
Share Pricen/a
Hisamitsu Pharmaceutical Co., Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4530 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Hisamitsu Pharmaceutical Co., Inc. Key Details
Last Reported Earnings
Nov 30, 2025
Next Reporting Earnings
n/a
- 285.25
- 59.05%
- 12.55%
- 0.9%
About 4530
- Founded
- 1847
- Employees
- 2799
- CEO
- WebsiteView website
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company offers OTC products, such as, external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. It also exports its products to Asia, the United States, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
